WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1999040940) LIGANDS OF THE CD47 ANTIGEN, AGENTS BINDING THE LIGANDS OF THE CD47 ANTIGEN AND USES THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1999/040940    International Application No.:    PCT/CA1999/000140
Publication Date: 19.08.1999 International Filing Date: 16.02.1999
Chapter 2 Demand Filed:    20.08.1999    
IPC:
A61K 38/00 (2006.01), C07K 14/705 (2006.01), C07K 16/28 (2006.01)
Applicants: SARFATI, Marie [CA/CA]; (CA)
Inventors: SARFATI, Marie; (CA)
Agent: ROBIC; 55 Rue Saint Jacques, Montréal, Quebec H2Y 3X2 (CA)
Priority Data:
2,226,962 16.02.1998 CA
Title (EN) LIGANDS OF THE CD47 ANTIGEN, AGENTS BINDING THE LIGANDS OF THE CD47 ANTIGEN AND USES THEREOF
(FR) LIGANDS DE L'ANTIGENE CD47, AGENTS LE FIXANT ET LEUR EMPLOI
Abstract: front page image
(EN)The present invention relates to ligands of the CD47, to agents binding these ligands and their uses. More particularly, the present invention relates to the uses of monoclonal antibodies specific to the CD47, thrombospondin, Tp47, SIRP$g(a), and fragments thereof, and to the use of soluble CD47-Fc, in pharmaceutical compositions for the treatment or the prophylaxis of various inflammatory, autoimmune and allergic diseases as well as in the treatment of graft rejection and/or chronic lymphocytic leukemia.
(FR)L'invention porte sur des ligands du CD47, des agents fixant ces ligands, et leur emploi, et en particulier sur l'utilisation d'anticorps monoclonaux spécifiques du CD47, de la trombospondine, du Tp47, du SIRP$g(a), et de leurs fragments. L'invention porte également sur l'emploi de CD47-Fc dans des préparations pharmaceutiques utilisées pour le traitement ou la prophylaxie de différents troubles de nature inflammatoire, autoimmunitaire, ou allergique, et pour le traitement du rejet des greffes et/ou celui de la leucémie lymphocytaire chronique.
Designated States: AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CU, CZ, DE, DK, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, UA, UG, US, UZ, VN, YU, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, SD, SZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)